|1.||Kim, Nam Deuk: 9 articles (10/2008 - 03/2003)|
|2.||Suh, Hongsuk: 8 articles (10/2008 - 03/2003)|
|3.||Yoo, Young Hyun: 8 articles (04/2007 - 03/2003)|
|4.||Choi, Yung Hyun: 5 articles (10/2008 - 09/2003)|
|5.||Park, Sang Eun: 2 articles (10/2008 - 07/2004)|
|6.||Park, Young Chul: 2 articles (10/2008 - 12/2003)|
|7.||Yee, Su-Bog: 2 articles (04/2007 - 09/2005)|
|8.||Kim, Jae Hong: 2 articles (04/2007 - 09/2005)|
|9.||Seo, Su Yeong: 2 articles (04/2007 - 03/2003)|
|10.||Im, Eunok: 2 articles (12/2006 - 11/2005)|
|1.||Hepatocellular Carcinoma (Hepatoma)
11/08/2008 - "This study suggested that HS-1200 is potentially useful as an apoptosis inducer for the treatment of hepatocellular carcinoma."
10/18/2008 - "The present study was undertaken to examine whether HS-1200 had an anticancer effect on HepG2 (wild-type p53) and Hep3B (p53 deleted) human hepatoma cells. "
11/08/2008 - "We investigated whether HS-1200 has anti-proliferation effects on human hepatoma cells in vitro. "
10/18/2008 - "A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells."
11/08/2008 - "Synthetic chenodeoxycholic acid derivative, HS-1200, induces apoptosis of human hepatoma cells via a mitochondrial pathway."
04/01/2007 - "The present study was undertaken to examine whether HS-1200 sensitizes radiation-induced apoptosis in MCF-7 human breast carcinoma cells. "
11/08/2005 - "Recently, we have reported that a synthetic derivative of ursodeoxycholic acid (UDCA), HS-1183, and those of chenodeoxycholic acid (CDCA), HS-1199 and HS-1200, induced apoptosis in human breast carcinoma cells through a p53-independent pathway. "
09/25/2003 - "The effects of synthetic derivatives of ursodeoxycholic acid (UDCA), HS-1183, and chenodeoxycholic acid (CDCA), HS-1199 and HS-1200, on the proliferation of human prostate carcinoma PC-3 cells were investigated. "
|3.||Glioblastoma (Glioblastoma Multiforme)
|4.||Colonic Neoplasms (Colon Cancer)
09/01/2005 - "The HS-1200 treatment significantly inhibited the increase of tumor size in NOD/SCID mice and prolonged the life spans. "
10/18/2008 - "We previously reported that HS-1200, a synthetic chenodeoxycholic acid derivative, has apoptosis-inducing activity in various human cancer cells. "
04/01/2007 - "HS-1200, a synthetic chenodeoxycholic acid derivative, has cytotoxic activity in various human cancer cells. "
12/01/2006 - "In addition to this, a chenodeoxycholic acid derivative, called HS-1200, significantly decreased the growth of TE671 medulloblastoma tumor size and increased life span in non-obese diabetic and severe combined immunodeficient (NOD/SCID) mice. "
|2.||Chenodeoxycholic Acid (Chenix)
|3.||Ursodeoxycholic Acid (Urso)
|7.||Cytochromes c (Cytochrome c)